ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
UroGen Pharma Ltd

UroGen Pharma Ltd (URGN)

9,29
-0,07
(-0,75%)
Geschlossen 28 Februar 10:00PM
9,29
0,00
( 0,00% )
Vor Marktöffnung: 11:06AM
Fortg. Diagramm

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
9,29
Gebot
9,25
Fragen
9,29
Volumen
-
0,00 Tagesbereich 0,00
9,21 52-Wochen-Bereich 20,70
Marktkapitalisierung
Handelsende
9,29
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
-
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
371.596
Ausgegebene Aktien
42.199.414
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-3,83
Gewinn pro Aktie (EPS)
-2,42
Erlöse
82,71M
Nettogewinn
-102,24M

Über UroGen Pharma Ltd

UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment opt... UroGen Pharma Ltd is a clinical stage biopharmaceutical company focused on developing novel therapies designed to change the standard of care for urological pathologies. The company has an innovative and broad pipeline of product candidates that can overcome the deficiencies of current treatment options for a variety of urological conditions with a focus on uro-oncology. Its lead product candidates, UGN-101 and UGN-102, are proprietary formulations of the chemotherapy drug Mitomycin C, or MMC, a generic drug, which is used off-label for urothelial cancer treatment only in a water-based formulation as an adjuvant, or supplemental post-surgery, therapy. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
Hauptsitz
Ra'anana, Center, Isr
Gegründet
-
UroGen Pharma Ltd is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker URGN. The last closing price for UroGen Pharma was US$9,29. Over the last year, UroGen Pharma shares have traded in a share price range of US$ 9,21 to US$ 20,70.

UroGen Pharma currently has 42.199.414 shares in issue. The market capitalisation of UroGen Pharma is US$392,03 million. UroGen Pharma has a price to earnings ratio (PE ratio) of -3.83.

URGN Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1-1.54-14.219759926110.8310.85549.214344409.73144411CS
4-1.97-17.495559502711.2611.879.2133606610.45014898CS
12-2.96-24.163265306112.2512.689.2137159610.70708699CS
26-4.93-34.669479606214.2214.579.2147570011.95228234CS
52-9.03-49.290393013118.3220.79.2149728213.97323447CS
1563.3756.92567567575.9224.134.8531715913.95435759CS
260-16.71-64.26923076922630.894.8525506115.33352356CS

URGN - Frequently Asked Questions (FAQ)

What is the current UroGen Pharma share price?
The current share price of UroGen Pharma is US$ 9,29
How many UroGen Pharma shares are in issue?
UroGen Pharma has 42.199.414 shares in issue
What is the market cap of UroGen Pharma?
The market capitalisation of UroGen Pharma is USD 392,03M
What is the 1 year trading range for UroGen Pharma share price?
UroGen Pharma has traded in the range of US$ 9,21 to US$ 20,70 during the past year
What is the PE ratio of UroGen Pharma?
The price to earnings ratio of UroGen Pharma is -3,83
What is the cash to sales ratio of UroGen Pharma?
The cash to sales ratio of UroGen Pharma is 4,74
What is the reporting currency for UroGen Pharma?
UroGen Pharma reports financial results in USD
What is the latest annual turnover for UroGen Pharma?
The latest annual turnover of UroGen Pharma is USD 82,71M
What is the latest annual profit for UroGen Pharma?
The latest annual profit of UroGen Pharma is USD -102,24M
What is the registered address of UroGen Pharma?
The registered address for UroGen Pharma is 9 HATAASIYA ST, PO BOX 2397, RA'ANANA, CENTER, 4365007
What is the UroGen Pharma website address?
The website address for UroGen Pharma is www.urogen.com
Which industry sector does UroGen Pharma operate in?
UroGen Pharma operates in the PHARMACEUTICAL PREPARATIONS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
STAKSTAK Inc
US$ 3,58
(130,97%)
106
PMAXPowell Max Ltd
US$ 0,6905
(93,96%)
22,94M
ARBBARB IOT Group Ltd
US$ 0,7801
(62,52%)
7,68M
BONBon Natural Life Ltd
US$ 1,44
(51,58%)
4
BSCSInvesco Bulletshares 2028 Corporate Bond ETF
US$ 29,99
(47,66%)
1
SPGCSacks Parente Golf Inc
US$ 0,1964
(-51,63%)
5,66M
NVNINVNI Group Ltd
US$ 1,25
(-37,50%)
60,26k
DCGODocGo Inc
US$ 2,80
(-28,57%)
33,21k
MBIOMustang Bio Inc
US$ 2,07
(-24,45%)
2,53k
DLODLocal Ltd
US$ 10,72
(-22,04%)
5,74k
VRPXVirpax Pharmaceuticals Inc
US$ 0,2955
(30,06%)
23,93M
PMAXPowell Max Ltd
US$ 0,6905
(93,96%)
22,94M
ARBBARB IOT Group Ltd
US$ 0,7801
(62,52%)
7,68M
SPGCSacks Parente Golf Inc
US$ 0,1964
(-51,63%)
5,66M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 12,51
(0,32%)
5,04M

URGN Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht